Intensive antihypertensive treatment and serious adverse events in older people

Area of Science:

• Gerontology
• Cardiology
• Clinical Trials

Background:

• Hypertension is a prevalent condition in older adults.
• Effective blood pressure management is crucial for reducing cardiovascular events.
• The safety of intensive blood pressure lowering in this demographic requires careful consideration.

Purpose of the Study:

• To evaluate the association between intensive systolic blood pressure lowering and adverse events like syncope, hypotension, and falls.
• To analyze the risks and benefits of different blood pressure targets in the elderly population.
• To inform clinical practice regarding hypertension management in older individuals.

Main Methods:

• Analysis of data from the Systolic Blood Pressure Intervention Trial (SPRINT).
• Inclusion of participants aged 50 years and older.
• Comparison of outcomes between intensive (<120 mmHg) and standard (<140 mmHg) systolic blood pressure targets.

Main Results:

• Intensive blood pressure lowering was associated with a higher incidence of syncope.
• Hypotension and falls were also observed more frequently in the intensive treatment group.
• The absolute risk increase for these adverse events needs to be weighed against cardiovascular benefits.

Conclusions:

• Intensive systolic blood pressure reduction in older adults may increase the risk of syncope, hypotension, and falls.
• Clinicians should carefully consider individual patient factors and potential risks when setting blood pressure targets.
• Further research may be needed to optimize hypertension treatment strategies for the elderly to minimize adverse events.